High‐dose Methotrexate Therapy—An Area of Uncertainty*
- 1 December 1979
- journal article
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 9 (6) , 722-732
- https://doi.org/10.1111/j.1445-5994.1979.tb04209.x
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Comparison of intravenous and oral high-dose methotrexate in treatment of solid tumours.BMJ, 1979
- Characterization of methotrexate recovered from the urine of high dose patients for the purpose of clinical re-usePublished by Elsevier ,1978
- Clinical Pharmacokinetics of Methotrexate1Clinical Pharmacokinetics, 1978
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate ToxicityNew England Journal of Medicine, 1977
- Reappearance of dihydrofolate reductase in rodent tissues following methotrexate administrationJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Plasma levels of methotrexate in cancer patients as studied by an improved spectrophotofluorometric methodBiochemical Medicine, 1974
- Threshold Methotrexate Concentration for In Vivo Inhibition of DNA Synthesis in Normal and Tumorous Target TissuesJournal of Clinical Investigation, 1973
- Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion patternPublished by Elsevier ,1972
- Eradication Of Leukaemic Cells (L1210) by Methotrexate and Methotrexate Plus Citrovorum FactorNature, 1966
- Long-Term Remissions in Childhood Acute LeukemiaClinical Pediatrics, 1966